NCT06563804
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06563804
Title A Study to Evaluate S227928 as a Single Agent and in Combination With Venetoclax in Patients With R/R AML, MDS/AML, or CMML
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Servier Bio-Innovation LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | FIN | DEU | AUS


No variant requirements are available.